6qgg: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
==Structure of human Bcl-2 in complex with analogue of ABT-737== | |||
<StructureSection load='6qgg' size='340' side='right'caption='[[6qgg]], [[Resolution|resolution]] 1.50Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[6qgg]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6QGG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6QGG FirstGlance]. <br> | |||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=J1H:[(3~{R})-3-[[4-[[4-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]phenyl]carbonylsulfamoyl]-2-nitro-phenyl]amino]-4-phenylsulfanyl-butyl]-(2-hydroxy-2-oxoethyl)-dimethyl-azanium'>J1H</scene></td></tr> | |||
[[Category: | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[6qg8|6qg8]], [[6qgk|6qgk]], [[6qgh|6qgh]], [[6qgj|6qgj]]</td></tr> | ||
[[Category: | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6qgg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6qgg OCA], [http://pdbe.org/6qgg PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6qgg RCSB], [http://www.ebi.ac.uk/pdbsum/6qgg PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6qgg ProSAT]</span></td></tr> | ||
</table> | |||
== Disease == | |||
[[http://www.uniprot.org/uniprot/BCL2_HUMAN BCL2_HUMAN]] Note=A chromosomal aberration involving BCL2 has been found in chronic lymphatic leukemia. Translocation t(14;18)(q32;q21) with immunoglobulin gene regions. BCL2 mutations found in non-Hodgkin lymphomas carrying the chromosomal translocation could be attributed to the Ig somatic hypermutation mechanism resulting in nucleotide transitions. | |||
== Function == | |||
[[http://www.uniprot.org/uniprot/BCL2_HUMAN BCL2_HUMAN]] Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1).<ref>PMID:18570871</ref> | |||
== References == | |||
<references/> | |||
__TOC__ | |||
</StructureSection> | |||
[[Category: Large Structures]] | |||
[[Category: Casara, P]] | |||
[[Category: Chen, I]] | [[Category: Chen, I]] | ||
[[Category: Davidson, J]] | [[Category: Davidson, J]] | ||
[[Category: Davis, B]] | [[Category: Davis, B]] | ||
[[Category: Diguarher, T Le]] | |||
[[Category: Dokurno, P]] | |||
[[Category: Geneste, O]] | |||
[[Category: Graham, C J]] | |||
[[Category: Harris, R]] | |||
[[Category: Hickman, J]] | [[Category: Hickman, J]] | ||
[[Category: Hubbard, R E]] | |||
[[Category: Jordan, A M]] | |||
[[Category: Kotschy, A]] | |||
[[Category: Matassova, N]] | |||
[[Category: Murray, J]] | |||
[[Category: Pedder, C]] | |||
[[Category: Ray, S]] | |||
[[Category: Roughley, S]] | |||
[[Category: Smith, J]] | |||
[[Category: Stark, J]] | [[Category: Stark, J]] | ||
[[Category: Walmsley, C]] | |||
[[Category: Wang, Y]] | |||
[[Category: Whitehead, N]] | [[Category: Whitehead, N]] | ||
[[Category: | [[Category: Williamson, D S]] | ||
[[Category: | [[Category: Abt-737]] | ||
[[Category: | [[Category: Apoptosis]] | ||
[[Category: | [[Category: Bcl2]] | ||